Despite recent advances, there continue to be significant issues that compromise the effective management of pulmonary arterial hypertension, writes Victoria Allan.
Victoria Allan
Advertisement
Victoria Allan is Head of Cardiovascular/Respiratory Therapy Monitors, Ipsos Healthcare.
Articles by Victoria Allan
Advertisement
Latest Updated Articles
Why Is It Such a Challenge to Treat PAH?Published: July 3rd 2015 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
4
Real-World Data Brings New Insights to Natural History of Disease Studies
5